Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Telemonitoring and experimentation in telemedicine for the improvement of healthcare pathways (ETAPES program). Sustainability beyond 2021: What type of organisational model and funding should be used?
Le Douarin Y, Traversino Y, Graciet A, Josseran A; participants of Giens XXXV Round Table Health, economy. Le Douarin Y, et al. Among authors: josseran a. Therapie. 2020 Jan-Feb;75(1):43-56. doi: 10.1016/j.therap.2019.12.009. Epub 2019 Dec 20. Therapie. 2020. PMID: 32014299 Review.
Medico-economic evaluation of health products in the context of the Social Security Financing Act for 2012.
Dervaux B, Baseilhac E, Fagon JY; participants of round table N°6 of Giens Workshops XXVIII (th); Ameye V, Angot P, Audry A, Becquemont L, Borel T, Cazeneuve B, Courtois J, Detournay B, Favre P, Granger M, Josseran A, Lassale C, Louvet O, Pinson J, de Pouvourville G, Rochaix L, Rumeau-Pichon C, de Saab R, Schwarzinger M, Sun A. Dervaux B, et al. Among authors: josseran a. Therapie. 2013 Jul-Aug;68(4):253-63. doi: 10.2515/therapie/2013045. Epub 2013 Aug 28. Therapie. 2013. PMID: 23981264 Free article. English, French.
Post-approval studies in France, challenges facing medical devices.
Levesque K, Coqueblin C, Guillot B; participants of round table n3 of Giens XXIX : Aubourg Lucie 4 Avouac Bernard 5 Carbonneil Cédric 6; Aubourg L, Avouac B, Carbonneil C, Cucherat M, Descamps-Mandine P, Hanoka S, Goldberg M, Josseran A, Parquin F, Pitel S, Ratignier C, Sechoy O, Szwarcenstein K, Tanti A, Teiger E, Thevenet N. Levesque K, et al. Among authors: josseran a. Therapie. 2014 Jul-Aug;69(4):303-21. doi: 10.2515/therapie/2014051. Epub 2014 Aug 12. Therapie. 2014. PMID: 25230354 English, French.
Assessment and non-clinical impact of medical devices.
Dervaux B, Szwarcensztein K, Josseran A; participants of round table N°4 of Giens XXX:; Barna A, Carbonneil C, Chevrie K, Debroucker F, Grumblat A, Grumel O, Massol J, Maugendre P, Méchin H, Orlikowski D, Roussel C, Rumeau-Pichon C, Sales JP, Vicaut E. Dervaux B, et al. Among authors: josseran a. Therapie. 2015 Jan-Feb;70(1):57-68. doi: 10.2515/therapie/2015004. Epub 2015 Mar 6. Therapie. 2015. PMID: 25747839 English, French.
Télésurveillance et expérimentations ETAPES. Quelle pérennité après 2021 : quel modèle organisationnel et financement ?
le Douarin Y, Traversino Y, Graciet A, Josseran A; et les participants à la table ronde 'Santé et économie' des Ateliers de Giens XXXV. le Douarin Y, et al. Among authors: josseran a. Therapie. 2020 Jan-Feb;75(1):29-42. doi: 10.1016/j.therap.2019.11.003. Epub 2019 Dec 13. Therapie. 2020. PMID: 31959354 French. No abstract available.
Place des mesures rapportées par les patients (PROMS/PREMS) dans l’évaluation et la valorisation des technologies de santé en France.
Roussel C, Chassany O, Durand-Zaleski I, Josseran A, Alter L, Auquier P, Bourguignon S, Cachoux J, Desforges C, Fernandez J, Gaudin AF, Germe AF, Haenel E, Olivier P, Maillard N, Naïditch N, Nguyen T, Péan C, Rumeau-Pichon C, Sales JP, Schmidely N, Tuppin P, Vray M. Roussel C, et al. Among authors: josseran a. Therapie. 2022 Jan-Feb;77(1):89-102. doi: 10.1016/j.therap.2022.01.007. Epub 2022 Jan 13. Therapie. 2022. PMID: 35115142 French. No abstract available.
26 results